GE HealthCare Highlights Nuclear Medicine Imaging and AI Tools at SNMMI 2026
New technologies showcased at SNMMI 2026 aim to support precision care and streamline workflows as adoption of targeted therapies grows.
New technologies showcased at SNMMI 2026 aim to support precision care and streamline workflows as adoption of targeted therapies grows.
Positrigo, a Swiss company, received FDA clearance for its NeuroLF brain PET system, designed to diagnose and monitor brain disorders.
According to a February 2015 market research report from Bio-Tech Systems Inc, advances in neurological and cardiac imaging are predicted to fuel United States growth for SPECT and PET radiopharmaceutical markets in the second half of the decade.
New technologies showcased at SNMMI 2026 aim to support precision care and streamline workflows as adoption of targeted therapies grows.